Jon Våbenø

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Structure Activity Relationship

Extracorporeal Membrane Oxygenation

Hematopoietic Stem Cell

Top Venues

Science signaling

ACS pharmacology & translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Jon Våbenø, Marta Oliva-Santiago, Astrid S Jørgensen, Stefanie Karlshøj, Mette Marie Rosenkilde
Identification of a Salt Bridge That Is Functionally Important for Chemokine Receptor CXCR1 but not CXCR2. ACS pharmacology & translational science 6 (8) (2023)
Olav Larsen, Wijnand J C van der Velden, Maša Mavri, Sara Schuermans, Pia C Rummel, Stefanie Karlshøj, Martin Gustavsson, Mieke Gouwy, Jon Våbenø, Mette Marie Rosenkilde
Identification of a conserved chemokine receptor motif that enables ligand discrimination. Science signaling 15 (724) (2022)
Christian Berg, Michael J Wedemeyer, Motiejus Melynis, Roman R Schlimgen, Lasse H Hansen, Jon Våbenø, Francis C Peterson, Brian F Volkman, Mette Marie Rosenkilde, Hans Rudolf Lüttichau
The non-ELR CXC chemokine encoded by human cytomegalovirus UL146 genotype 5 contains a C-terminal β-hairpin and induces neutrophil migration as a selective CXCR2 agonist. PLoS pathogens 18 (3) (2022)
Astrid Sissel Jørgensen, Viktorija Daugvilaite, Katia De Filippo, Christian Berg, Masa Mavri, Tau Benned-Jensen, Goda Juzenaite, Gertrud Hjortø, Sara Rankin, Jon Våbenø, Mette Marie Rosenkilde
Biased action of the CXCR4-targeting drug plerixafor is essential for its superior hematopoietic stem cell mobilization. Communications biology 4 (1) (2021)
Viktoria M S Kjaer, Loukas Ieremias, Viktorija Daugvilaite, Michael Lückmann, Thomas M Frimurer, Trond Ulven, Mette M Rosenkilde, Jon Våbenø
Discovery of GPR183 Agonists Based on an Antagonist Scaffold. ChemMedChem 16 (17) (2021)